**Specifications Table**TableSubject area*Toxicology*More specific subject area*Food toxicology, systemic oxidative stress and inflammation*Type of data*Figures, Table.*How data was acquired*All data was acquired using the POLARstar Omega multi-mode microplate reader(BMG LABTECH Inc., Cary, NC, USA)*Data format*Analyzed data*Experimental factors*Urine and serum from rats exposed to dietary acrylamide were processed and individual enzyme-linked immunosorbent assays (ELISAs) were performed to investigate markers of oxidative stress and inflammation.*Experimental features*Male F344 rats were fed an AIN−93 G basal diet containing low fat (7% wt/wt) or high fat (23.9% wt/wt) and 0, 5, 10, or 50 mg/kg diet acrylamide for 8 weeks. Rats were placed in metabolic cages 24 h before necropsy for urine sample collection. Blood samples were collected from abdominal aorta at necropsy*Data source location*Ottawa, Ontario, Canada*Data accessibility*Data is with this article*

Value of the data {#s0005}
=================

•We explored the role of chronic exposure to food-borne acrylamide in modulating markers of systemic oxidative stress and inflammation in rats under low and high fat diet conditions.•This systemic biochemical data will support previous findings of acrylamide exposure at doses known to cause rodent tumors.•Our data will be beneficial in updating the existing toxicity information available on food-borne acrylamide for regulatory purposes.

1. Data {#s0010}
=======

The present dataset includes results of biochemical estimations that determined markers of systemic oxidative stress and inflammation in urine and serum samples of F344 rats exposed to dietary acrylamide ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}, [Fig. 8](#f0040){ref-type="fig"}, [Fig. 9](#f0045){ref-type="fig"}, [Fig. 10](#f0050){ref-type="fig"}; [Table 2](#t0010){ref-type="table"}). These results of individual biochemical markers are to be interpreted with the clinical biochemistry, hematology and pathology data previously reported [@bib1].

2. Experimental design, materials and methods {#s0015}
=============================================

2.1. Animals, care and diets {#s0020}
----------------------------

The experimental protocol involving animals was reviewed and approved by the Health Canada Ottawa Animal Care Committee prior to the commencement of the study. Animals were cared for according to the guidelines of the Canadian Council on Animal Care. Six-week-old male F344 rats were procured from Charles River Laboratories Canada (St. Constant, Quebec, Canada) and were pair-housed in laboratory conditions with a 12 h light/12 h dark cycle. Temperature and relative humidity were controlled at 22 °C and 55%, respectively. All animals were acclimatized to the above conditions for 1 week until initiation of the experiment. The rats had free access to either lab chow (during the acclimatization phase) or experimental diets and drinking water *ad libitum*. The experimental diets were isocaloric and based on the AIN-93G rodent semisynthetic diet formula [@bib2], but containing corn oil instead of soy oil as published earlier [@bib3]. Fat level in the diet was maintained at either low (7%, wt/wt) or high (23.9%, wt/wt). Diets were obtained from Research Diets, Inc. (New Brunswick, NJ, USA) in the form of powder. Acrylamide was mixed with the diets at the required dose using a Hobart mixer, and then made into pellets using a pelleting press. Diets were never exposed to high temperature during processing and were stored in the dark at 4 °C until use. Rats were monitored every day and their body weights and food consumption were recorded twice a week; diets were replenished weekly.

2.2. Experimental design {#s0025}
------------------------

After the acclimatization phase, animals (*n*=64) were randomized (2×4 factorial) into eight dietary groups (*n*=8 rats/group) to receive low or high fat diets without or with acrylamide (0, 5, 10 or 50 mg/kg diet). All animals remained on the experimental diets for a total of 10 weeks. A day before euthanasia, animals (not fasted) were placed in metabolic cages overnight, after which urine was collected (on ice) and urine volume was recorded for assay dilutions and calculations. Following urine collection, all rats were killed by exsanguination under isoflurane anesthesia, and blood was drawn from the abdominal aorta into BD Vacutainer SST™ blood collection tubes (Becton-Dickinson, Franklin Lakes, NJ, USA). Urine was centrifuged at 4000×*g* and serum was separated by centrifugation at 700×*g*, and in both cases the supernatant was collected, aliquots prepared, and stored at −80 °C until analysis.

2.3. Enzyme-linked immunosorbent assay (ELISA) {#s0030}
----------------------------------------------

Urine samples were analyzed for 8-hydroxydeoxyguanosine and isoprostane, and serum samples for total antioxidant capacity, paraoxonase 1 activity, c-reactive protein, homocysteine, oxidized low-density lipoproetein, intercellular adhesion molecule-1, thromboxin 2, and Nε-(carboxymethyl)lysine carried out by the ELISA method using commercial kits according to the manufacturer׳s instructions. Details of the kits and test sample dilutions of individual assays are given in [Table 1](#t0005){ref-type="table"}.

2.4. Statistical analysis {#s0035}
-------------------------

Data was analyzed performed using SigmaPlot 11.0. Statistical comparisons were performed using ANOVA with Tukey׳s post hoc test. For all tests, *p*\<0.05 was considered as statistically significant.

Appendix A. Supplementary material {#s0045}
==================================

Supplementary material
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Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2016.02.024](http://dx.doi.org/10.1016/j.dib.2016.02.024){#ir0005}.

![Urinary 8-hydroxydeoxyguanosine (8OHdG) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "aaa", "bbb", and "ccc" are significantly different from "A", "B", and "C" respectively at *p*\<0.001. "d" is significantly different from "D" at *p*\<0.05. "\*" indicates significant difference at *p*\<0.05.](gr1){#f0005}

![Urinary isoprostane levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "\*" indicates significant difference at *p*\<0.05.](gr2){#f0010}

![Serum total antioxidant capacity (TAC) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM.](gr3){#f0015}

![Serum paraoxonase 1 (PON1) activity in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "a" is significantly different from "A" at *p*\<0.05. "\*" indicates significant difference at *p*\<0.05.](gr4){#f0020}

![Serum c-reactive protein (CRP) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "a" and "b" are significantly different from "A" and "B" at *p*\<0.05, respectively. "aa" is significantly different from "A" at *p*\<0.01. "\*" and "\*\*" indicate significant difference at *p*\<0.05 and *p*\<0.01, respectively.](gr5){#f0025}

![Serum homocysteine level in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "aaa" is significantly different from "A" at *p*\<0.001.](gr6){#f0030}

![Serum oxidized low-density lipoprotein (Ox-LDL) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet), *n*=8/group. The histograms represent mean values±SEM.](gr7){#f0035}

![Serum intercellular adhesion molecule-1 (ICAM-1) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM. "aaa" is significantly different from "A" at p\<0.001. "\*" and "\*\*" indicate significant difference at *p*\<0.05 and *p*\<0.01, respectively.](gr8){#f0040}

![Serum thromboxin 2 (TBX2) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet, *n*=8/group. The histograms represent mean values±SEM.](gr9){#f0045}

![Serum Nε-(carboxymethyl)lysine (CML) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg diet. The histograms represent mean values±SEM, *n*=8/group.](gr10){#f0050}

###### 

Manufacturer details of commercial kits used and test sample dilution factor for individual assays.

Table 1

  ----------------------------------- ---------------- ------------------------------------------------------ -------------------------
  Assay name                          Catalog number   Manufacturer (City, Country)                           Dilution of urine/blood
                                                                                                              
  8-hydroxydeoxyguanosine             KOG-200 S/E      JaICA Shizuoka, Japan                                  1×urine
  Isoprostane                         EA85             Oxford Biomedical Research, Rochester Hills, MI, USA   10×urine
  Total antioxidant capacity          NX 2332          Randox Laboratiories, Antrim, UK                       1×serum
  Paraoxonase 1                       E33702           Thermo Fisher Scientific Inc. Waltham, MA, USA         170×serum
  c-Reactive protein (CRP)            41-CRPRT-E01     Alpco Salem, NH, USA                                   12,000×serum
  Homocysteine (HCy)                  194-5361         Bio-Rad Laboratories, Inc. Hercules, CA, USA           1×serum
  Oxidized LDL                        10-1158-01       Mercodia AB Uppsala, Sweden                            21×serum
  Intercellular adhesion molecule-1   RIC100           R&D Systems Minneapolis, MN, USA                       51×serum
  Thromboxin 2                        900-002          Assay Designs, Inc., Ann Arbor, MI, USA                400×serum
  Nε-(carboxymethyl)lysine            CY-8066          CycLex Co., Ltd. Nagano-shi. Japan                     6×serum
  ----------------------------------- ---------------- ------------------------------------------------------ -------------------------

###### 

Spearman correlation (coefficient) between acrylamide dose and oxidative stress and inflammatory markers.

Table 2

  Marker          8OHdG         Isoprostane   TAC       PON1         CRP            HCy          Ox-LDL    ICAM-1         TBX2   CML
  --------------- ------------- ------------- --------- ------------ -------------- ------------ --------- -------------- ------ -----
  Low fat diet                                                                                                                   
  Acrylamide      0.681\*\*\*   NS            NS        0.418\*      NS             −0.563\*\*   NS        NS             NS     NS
  8OHdG           NS            0.461\*       NS        NS           NS             NS           NS        NS             NS     NS
  Isoprostane     NS            NS            NS        0.519\*      NS             NS           NS        NS             NS     NS
  TAC             NS            NS            NS        NS           NS             NS           NS        NS             NS     NS
  PON1            NS            NS            0.392\*   NS           NS             NS           NS        −0.399\*       NS     NS
  CRP             NS            NS            NS        NS           NS             0.430\*      NS        NS             NS     NS
  Hcy             NS            NS            NS        NS           NS             NS           NS        0.443\*        NS     NS
  Ox-LDL          NS            NS            NS        NS           NS             NS           NS        0.500\*\*      NS     NS
  ICAM-1          NS            NS            NS        NS           NS             NS           NS        NS             NS     NS
  TBX2            NS            NS            NS        NS           NS             NS           NS        NS             NS     NS
  High fat diet                                                                                                                  
  Acrylamide      0.636\*\*\*   NS            NS        −0.487\*\*   −0.711\*\*\*   NS           NS        −0.615\*\*\*   NS     NS
  8OHdG           NS            NS            NS        −0.363\*     −0.769         −0.536\*\*   NS        −0.646\*\*\*   NS     NS
  Isoprostane     NS            NS            NS        NS           NS             NS           0.509\*   NS             NS     NS
  TAC             NS            NS            NS        NS           NS             NS           NS        NS             NS     NS
  PON1            NS            NS            NS        NS           0.408\*        NS           NS        0.409\*        NS     NS
  CRP             NS            NS            NS        NS           NS             0.451\*\*    NS        0.623\*\*\*    NS     NS
  Hcy             NS            NS            NS        NS           NS             NS           NS        0.380\*        NS     NS
  Ox-LDL          NS            NS            0.383\*   NS           NS             NS           NS        NS             NS     NS
  ICAM-1          NS            NS            NS        NS           NS             NS           NS        NS             NS     NS
  TBX2            NS            NS            NS        NS           NS             NS           NS        NS             NS     NS

"\*","\*\*" and \"\*\*\*\" indicate significant difference at *p*\<0.05, *p*\<0.01 and *p*\<0.001, respectively.
